Results 71 to 80 of about 8,704 (178)

Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece

ClinicoEconomics and Outcomes Research, 2016
Kostas Athanasakis,1 Aikaterini Bilitou,2 Dawn Lee,3 Eleftheria Karampli,1 Apostolos Karavidas,4 John Parissis,5 Georgia Sykara,2 John Kyriopoulos1 1Department of Health Economics, National School of Public Health, Athens, Greece; 2Pfizer Hellas, Athens,
Athanasakis K, Bilitou A, Lee D, Karampli E, Karavidas A, Parissis J, Sykara G, Kyriopoulos J   +7 more
doaj  

Eplerenone [PDF]

, 2020
openaire   +1 more source

Eplerenone

Journal of the American College of Cardiology, 2013
Bart, Bradley A., Nelson, Sarah
openaire   +1 more source

Late-gestation mineralocorticoid receptor antagonism lowers maternal blood pressure and attenuates placental insufficiency induced by leptin in pregnant mice. [PDF]

Am J Physiol Heart Circ Physiol
Sones JL.
europepmc   +1 more source

Ultrawide-field indocyanine angiography changes post 12 weeks of eplerenone in central serous chorioretinopathy. [PDF]

Indian J Ophthalmol
Sagar A, Mishra S, Kumar P, Sati A, Gupta A, Avasthi A, Srujana D, Dhar S, Khaleel M, Joshi A.   +9 more
europepmc   +1 more source

Mineralocorticoid receptor antagonists in heart failure with sustained monomorphic ventricular tachycardia: comparative analysis of spironolactone versus eplerenone. [PDF]

Open Heart
Szakál I, Komlósi F, Tóth P, Arnóth B, Bohus G, Vámosi P, Szegedi N, Salló Z, Osztheimer I, Perge P, Orbán G, Kardos A, Merkely B, Gellér L, Nagy KV.   +14 more
europepmc   +1 more source

Development and validation of stability indicating RP-HPLC method for the simultaneous estimation of dapagliflozin and eplerenone in bulk and synthetic mixture. [PDF]

BMC Chem
Tandel P, Mehta H.
europepmc   +1 more source

Mineralocorticoid receptor antagonists for the treatment of heart failure and kidney disease: a state-of-the-art review. [PDF]

Heart Fail Rev
Van Spall HGC, Vardeny O.
europepmc   +1 more source

Proteomic Profile After Intervention With Eplerenone Among Persons With HIV. [PDF]

Open Forum Infect Dis
Murthy A, Kolossváry M, Walpert AR, Sanchez E, Abohashem S, Tawakol A, Adler GK, Grinspoon SK, Srinivasa S.   +8 more
europepmc   +1 more source

Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease: Clinical Evidence, Pharmacology, and Drug-Drug Interactions for Personalized Management of Hyperkalemia. [PDF]

Int J Mol Sci
Hirai T, Katayama K.
europepmc   +1 more source